BioCardia closes $5.1M net equity offering with insider participation

BioCardia, Inc.

Sold 4,800,000 shares of common stock and warrants for 4,800,000 shares at combined price of $1.25 per unit, raising $6M gross proceeds.
Net proceeds expected to be approximately $5.1 million after deducting placement agent fees and expenses.
Directors and executive officers purchased 734,400 shares/warrants, contributing $0.9M of gross proceeds.
Warrants immediately exercisable at $1.25 per share, expiring September 20, 2027, with 4.99% beneficial ownership limitation.
Company agreed to no additional equity issuance until Nov 18, 2025, and no variable rate transactions until Mar 19, 2026.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.